Associated Papers
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
Raaijmakers MI et al.
Oncotarget, 2016
27791198 (PubMed )
Supplement: oncotarget-07-77163-s002.xlsx › M121224
IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas.
Ichimura K et al.
Neuro-oncology, 2009
Select a paper to view details